###begin article-title 0
Genes to Diseases (G2D) Computational Method to Identify Asthma Candidate Genes
###end article-title 0
###begin p 1
Conceived and designed the experiments: CPI MAAN CL. Performed the experiments: CP AT CPI CL. Analyzed the data: KT ML GMH CPI CL. Contributed reagents/materials/analysis tools: KT ML CP. Wrote the paper: KT.
###end p 1
###begin p 2
###xml 874 877 874 877 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LPA</italic>
###xml 879 883 879 883 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOX3</italic>
###xml 885 889 885 889 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNX9</italic>
###xml 891 895 891 895 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VIL2</italic>
###xml 897 900 897 900 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VIP</italic>
###xml 902 907 902 907 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADAM8</italic>
###xml 909 914 909 914 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DOCK1</italic>
###xml 916 921 916 921 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FANK1</italic>
###xml 923 929 923 929 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GPR123</italic>
###xml 934 939 934 939 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPRE</italic>
###xml 1300 1305 1300 1305 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPRE</italic>
Asthma is a complex trait for which different strategies have been used to identify its environmental and genetic predisposing factors. Here, we describe a novel methodological approach to select candidate genes for asthma genetic association studies. In this regard, the Genes to Diseases (G2D) computational tool has been used in combination with a genome-wide scan performed in a sub-sample of the Saguenay-Lac-St-Jean (SLSJ) asthmatic familial collection (n = 609) to identify candidate genes located in two suggestive loci shown to be linked with asthma (6q26) and atopy (10q26.3), and presenting differential parent-of-origin effects. This approach combined gene selection based on the G2D data mining analysis of the bibliographic and protein public databases, or according to the genes already known to be associated with the same or a similar phenotype. Ten genes (LPA, NOX3, SNX9, VIL2, VIP, ADAM8, DOCK1, FANK1, GPR123 and PTPRE) were selected for a subsequent association study performed in a large SLSJ sample (n = 1167) of individuals tested for asthma and atopy related phenotypes. Single nucleotide polymorphisms (n = 91) within the candidate genes were genotyped and analysed using a family-based association test. The results suggest a protective association to allergic asthma for PTPRE rs7081735 in the SLSJ sample (p = 0.000463; corrected p = 0.0478). This association has not been replicated in the Childhood Asthma Management Program (CAMP) cohort. Sequencing of the regions around rs7081735 revealed additional polymorphisms, but additional genotyping did not yield new associations. These results demonstrate that the G2D tool can be useful in the selection of candidate genes located in chromosomal regions linked to a complex trait.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 94 97 94 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002907-Maddox1">[1]</xref>
###xml 99 102 99 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002907-Cookson1">[2]</xref>
###xml 562 565 562 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002907-Blumenthal1">[3]</xref>
###xml 620 623 620 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002907-Blumenthal1">[3]</xref>
###xml 624 627 624 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002907-Hoffjan1">[5]</xref>
###xml 764 767 764 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002907-Rannala1">[6]</xref>
###xml 768 771 768 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002907-Laitinen1">[8]</xref>
###xml 328 333 <span type="species:ncbi:9606">human</span>
Asthma involves genetic and environmental factors in its development, chronicity and severity [1], [2]. Although some of its underlying mechanisms have been elucidated in recent years, more work is needed to gain a clearer understanding of genetic determinants. The mapping of asthma has been one of the most important areas of human genetics in the last two decades. According to an overview by Blumenthal (2005), twelve complete and two incomplete genome scans for asthma have been published, identifying a total of twenty chromosomal linked regions to asthma [3]. Discrepancies often appeared between linkage studies [3]-[5], leading to the use of standard phenotype definitions and founder populations as a way to decrease phenotypic and genetic heterogeneity [6]-[8].
###end p 4
###begin p 5
###xml 305 308 305 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002907-Hoffjan2">[9]</xref>
###xml 310 314 310 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002907-Ober2">[10]</xref>
###xml 628 632 628 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002907-Heyer1">[11]</xref>
###xml 633 637 633 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002907-Lander1">[16]</xref>
###xml 760 764 760 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002907-PerezIratxeta1">[17]</xref>
###xml 766 770 766 770 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002907-PerezIratxeta2">[18]</xref>
To date, common strategies have been employed to identify genes involved in asthma predisposition. Linkage studies followed by positional cloning identified six genes while association studies identified over a hundred genes, the majority of these having quite small effects on asthma susceptibility (see [9], [10] for a review). Here, we describe a novel methodological approach that combines classical genetic approaches with a computational data-mining tool. In this regard, a genome-wide scan for asthma and atopy in families originating from the Saguenay-Lac-St-Jean (SLSJ) founder population (Northeastern Quebec, Canada) [11]-[16] has been combined with the Genes to Diseases (G2D) new computational tool in the prioritization of asthma candidate genes [17], [18]. G2D performs the selection of the candidates in the chromosomal regions genetically linked to a disease by highlighting genes whose functions are related to the phenotype of the disease according to a data mining analysis of the bibliographic and protein public databases, or according to the genes already known to be associated with the same or a similar phenotype.
###end p 5
###begin p 6
###xml 739 742 739 742 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LPA</italic>
###xml 744 748 744 748 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOX3</italic>
###xml 750 754 750 754 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNX9</italic>
###xml 756 760 756 760 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VIL2</italic>
###xml 762 765 762 765 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VIP</italic>
###xml 767 772 767 772 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADAM8</italic>
###xml 774 779 774 779 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DOCK1</italic>
###xml 781 786 781 786 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FANK1</italic>
###xml 788 794 788 794 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GPR123</italic>
###xml 799 804 799 804 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPRE</italic>
###xml 976 981 976 981 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPRE</italic>
Single nucleotide polymorphisms (SNPs) within the candidate genes prioritized by the G2D tool have been subsequently used to conduct an association study with asthma, atopy and allergic asthma phenotypes in the SLSJ asthma familial collection. The chromosomal regions around associated SNPs have then been sequenced in order to find causal mutations, and a replication of the positive association findings has been assessed in the Childhood Asthma Management Program (CAMP) independent cohort. The goal was to apply the G2D tool in the search of genetic determinants associated with a complex trait, using asthma as a model. This approach led to the hypothesis-driven identification of ten genes that may not have been selected otherwise (LPA, NOX3, SNX9, VIL2, VIP, ADAM8, DOCK1, FANK1, GPR123 and PTPRE). Of these, one positive genetic association, resisting to corrections for multiple testing, has been found between the protein tyrosine phosphatase receptor type E gene (PTPRE) and allergic asthma in the SLSJ sample.
###end p 6
###begin title 7
Methods
###end title 7
###begin title 8
Subjects
###end title 8
###begin p 9
###xml 127 131 127 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002907-Poon1">[19]</xref>
###xml 132 136 132 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002907-Begin1">[21]</xref>
###xml 155 162 155 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002907-t001">Table 1</xref>
###xml 665 673 665 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002907.s002">Table S1</xref>
Clinical evaluation and phenotyping criteria of the Saguenay-Lac-St-Jean (SLSJ) subjects have been described in recent reports [19]-[21] and summarized in Table 1. This familial sample is predominantly composed of probands that reported an onset age of asthma below 12 years old (81.6% of the probands). The mean age of onset for the probands is 7 years and the mean age of onset for the asthmatic family members is 22 years. The entire sample has been used for the association study while for the genome scan, the first 79 recruited families, that were available at the time when the genome scan was performed have been used (n = 609 individuals-see supplementary Table S1 for subjects characteristics and studied phenotypes). The Chicoutimi Hospital local ethics committee approved the study and all subjects provided informed consent.
###end p 9
###begin title 10
Clinical and phenotypic characteristics of the Saguenay-Lac-St-Jean association study sample subjects.
###end title 10
###begin p 11
###xml 3 4 3 4 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
FEV1 = Geometric mean of the force expiratory volume in one second evaluated for 208 probands and for 683 family members.
###end p 11
###begin p 12
###xml 2 4 2 4 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">20</sub>
PC20 = Concentration of methacholine inducing a 20% fall in FEV1. Geometric mean and SD were obtained from the log transformed PC20 values. Evaluated for 186 probands and for 614 family members.
###end p 12
###begin p 13
IgE = Immunoglobulin E serum concentration. Geometric mean and SD were obtained from the log transformed IgE values. Evaluated for 211 probands and 704 family members.
###end p 13
###begin p 14
Present asthma or past documented clinical history of asthma. The reported mean age of onset is 7 years among the asthmatic probands and 22 years among the asthmatic family members.
###end p 14
###begin p 15
Defined as at least one positive response on skin prick testing (wheal diameter >3 mm at 10 minutes).
###end p 15
###begin title 16
Genome Scan
###end title 16
###begin p 17
###xml 1328 1332 1328 1332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002907-Kong1">[22]</xref>
###xml 1334 1338 1334 1338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002907-Kruglyak1">[23]</xref>
###xml 1581 1585 1581 1585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002907-Lemire1">[24]</xref>
###xml 31 43 <span type="species:ncbi:9606">participants</span>
###xml 343 348 <span type="species:ncbi:9606">Human</span>
DNA was extracted for all SLSJ participants from whole blood by using the QIAGEN genomic purification procedure (QIAGEN Inc., Valencia, CA). Genotyping was completed on 367 autosomal and 21 X-chromosome microsatellite markers evenly spaced throughout the genome (average spacing of 9.2 cM). The marker set is a modification of the Cooperative Human Linkage Centre Screening Set (, version 6.0), showing an average heterozygosity of 0.72 in our data set. Each primer was amplified separately and then pooled into panels of eight markers and products were interrogated using ABI 3700 sequencers (Applied Biosystems, Foster City, CA) with a size standard ladder. Duplicate of two CEPH control DNAs and one water were included in each genotyping plate. In our data set of 195939 autosomal genotypes, 91.4% of the alleles were called and the proportion of observed Mendelian error was 1.2%. Linkage of chromosomal regions with putative genetic risk factors for a given trait was assessed by evaluating the extent of excess sharing of alleles identical by descent in affected relatives within families. Test statistics are reported on the LOD scale. Briefly, a multipoint, one-parameter likelihood ratio test that is robust against incompleteness of marker data (when the descent of alleles in a pedigree is not fully known) was used [22], [23]. We moreover evaluated the specific contribution of mothers and fathers to the test of linkage, to look for parent-of-origin effects. The above tests of linkage, linkage through mothers and linkage through fathers are described in details in [24].
###end p 17
###begin title 18
Genes to Diseases (G2D)
###end title 18
###begin p 19
###xml 221 225 221 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002907-PerezIratxeta2">[18]</xref>
###xml 509 513 509 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002907-Ashburner1">[25]</xref>
###xml 1050 1054 1050 1054 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002907-PerezIratxeta1">[17]</xref>
###xml 1056 1060 1056 1060 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002907-PerezIratxeta2">[18]</xref>
The G2D tool has been applied in the two best genome scan susceptibility regions: 6q26 between markers D6S476 and D6S305, and 10q26.3 between markers D10S1223 and D10S1248. We used two of the approaches considered in G2D [18] to pre-select gene lists in these regions. The first approach uses a description of the phenotype to point to genes in a region. This method works with automatically derived relationships between the disease symptoms (as MeSH C terms) and gene features (as Gene Ontology or GO terms [25]) that are obtained from the literature and Entrez gene database (). We call this procedure the "PHENOTYPE" method. The second approach consists on automatically finding genes in a region that are similar to other genes previously associated to asthma. To do this, G2D measures the semantic distance between the annotations of the "known genes" and the annotations of genes in the problem region assigned by homology searches. We call this procedure the "KNOWN GENES" method. For details about the algorithm see the G2D web site at  and [17], [18].
###end p 19
###begin title 20
Association Study
###end title 20
###begin title 21
SNP selection
###end title 21
###begin p 22
###xml 207 211 207 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002907-Barrett1">[26]</xref>
###xml 222 223 222 223 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 408 416 408 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002907.s003">Table S2</xref>
The HapMap database () has been used to identify SNPs assumed to be polymorphic in the SLSJ population. TagSNPs were then selected with the tagger program implemented in the Haploview software (version 3.32)[26] using an r2 cutoff of 0.8 and a minor allele frequency (MAF) over 0.10 to cover each whole gene. SNPs were also prioritized on their localization (coding or untranslated regions-see supplementary Table S2). All SNPs are referred using their reference sequence number (rs#).
###end p 22
###begin title 23
SNP genotyping
###end title 23
###begin p 24
###xml 166 174 164 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002907.s003">Table S2</xref>
###xml 566 570 564 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002907-Oeth1">[27]</xref>
###xml 714 722 712 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002907.s003">Table S2</xref>
###xml 1077 1085 1064 1072 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002907.s004">Table S3</xref>
Eighty SNPs have been genotyped by the Sequenom(R) matrix-assisted laser desorption/ionization time-of-flight mass array spectrometer (Sequenom Inc., San Diego, CA) (Table S2). Sequenom primers were designed using the Sequenom SNP Assay Design software version 3.0 for iPLEX reactions. A total of 74 assays were designed for a single multiplex reaction. The assay group file containing the PCR primers and the iPLEX extension probes can be supplied on request to the corresponding author. The protocol and reaction conditions are in accordance with the manufacturer [27]. The genotypes were viewed and analyzed using the MassARRAY Typer software version 3.4 (Sequenom Inc., San Diego, CA). The ten remaining SNPs (Table S2) have been genotyped by the TaqMan(R) SNP Genotyping Assays (Applied Biosystems, Foster City, CA) using the Rotor-Genetrade mark real-time PCR (Corbett Research Ltd, Sydney, Australia). Protocol and method were supplied by the manufacturer and PCR conditions were optimized to get a good cluster separation between different genotypes (see supplementary Table S3 for PCR conditions). Genotypes were attributed by the Rotor Gene software using the scatter graph analysis option.
###end p 24
###begin title 25
Statistical analysis
###end title 25
###begin p 26
###xml 133 137 133 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002907-Lake1">[28]</xref>
###xml 138 142 138 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002907-Laird1">[30]</xref>
###xml 363 367 363 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002907-Li1">[31]</xref>
###xml 406 410 406 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002907-Nyholt1">[32]</xref>
###xml 438 445 438 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002907.s001">Text S1</xref>
###xml 716 720 716 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002907-Barrett1">[26]</xref>
Family-based association testing has been performed with the FBAT software (version 1.7) using an empirical estimate of the variance [28]-[30] to correctly account for linkage. A Sidak correction for multiple testing has been applied on the p-values accounting for the effective number of independent phenotypes and SNPs, according to the definition of Li and Ji [31], as implemented in the SNPSpD program [32] (see the online supporting Text S1 file for supplementary details). Parent-specific transmission disequilibrium tests were performed using sib_tdt from the ASPEX package (). Mendelian errors have been assessed by FBAT and Hardy-Weinberg equilibrium has been assessed with Haploview software (version 3.32)[26].
###end p 26
###begin title 27
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPRE</italic>
PTPRE Sequencing
###end title 27
###begin p 28
###xml 66 70 66 70 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002907-Bouchard1">[33]</xref>
###xml 153 158 153 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPRE</italic>
###xml 186 191 186 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPRE</italic>
###xml 417 425 417 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002907.s005">Table S4</xref>
Forty unrelated SLSJ subjects (validated with the BALSAC database [33]) presenting full-fit allergic asthmatic criteria and that have contributed to the PTPRE association were selected. PTPRE sequence information was obtained from Ensembl database (, release 46). The sequencing was divided in six regions that spanned 2.7 kb, starting from the exon 2 to the exon 4. Oligonucleotides and PCR conditions are listed in Table S4. Amplification products were purified with multiscreen PCR plates (Millipore Corporation, Billerica, MA), sequenced with BigDye terminator v3.1 chemistry following instructions of the manufacturer and analyzed on a 3100 Genetic analyzer (Applied Biosystems, Foster City, CA). Sequence analysis was performed with Codoncode Aligner software (CodonCode Corporation, ). The identified SNPs presenting MAF over 0.05 have been genotyped in the SLSJ sample using a Sequenom panel and analyzed with FBAT, as described above. Newly described SNPs have been submitted to NCBI () SNP database.
###end p 28
###begin title 29
Replication Study
###end title 29
###begin p 30
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPRE</italic>
###xml 106 110 106 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002907-The1">[34]</xref>
###xml 112 116 112 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002907-The2">[35]</xref>
###xml 254 259 254 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPRE</italic>
###xml 367 375 365 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002907.s004">Table S3</xref>
###xml 168 176 <span type="species:ncbi:9606">children</span>
###xml 641 646 <span type="species:ncbi:9606">Women</span>
###xml 793 805 <span type="species:ncbi:9606">participants</span>
The PTPRE rs7081735 association has been assessed in the Childhood Asthma Management Program (CAMP) study [34], [35]. This analysis includes the 497 non-Hispanic white children and their parents for whom adequate DNA was available. The genotyping of the PTPRE rs7081735 was performed using a TaqMan(R) SNP Genotyping Assays (Applied Biosystems, Foster City, CA) (see Table S3 for PCR conditions). Plates were scanned using the 7900HT Fast Real-Time PCR System (Applied Biosystems, Foster City, CA) and genotypes were assigned by the SDS 2.2 software using the scatter graph analysis option. The Institutional Review Board of the Brigham and Women's Hospital (BWH), as well as those of the other CAMP study centers, approved this study. Informed assent and consent were obtained from the study participants and their parents to collect DNA for genetic studies.
###end p 30
###begin title 31
Results
###end title 31
###begin title 32
Genome Scan
###end title 32
###begin p 33
###xml 169 177 169 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002907-g001">Figure 1</xref>
###xml 1123 1127 1121 1125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002907-Lander2">[36]</xref>
The genome-wide linkage scan analysis revealed at least two regions showing suggestive evidence for linkage, as well as differential maternal and paternal contribution (Figure 1). The two regions are 6q26 for asthma (LOD = 1.54, p = 0.0038) and 10q26.3 for atopy (LOD = 2.82, p = 0.00016). In these two regions, affected sibs tend to share more alleles inherited from the mothers than from the fathers. The linkage tests through the mothers reach a LOD of 2.19 (p = 0.00074) in 6q26 for asthma and a LOD of 2.96 (p = 0.00011) in 10q26.3 for atopy. The respective LODs obtained through the fathers at the same loci are only 0.01 (p = 0.40) and 0.58 (p = 0.05). Moreover, even though the 10q region does not show a great strength of linkage with asthma (LOD = 0.57, p = 0.051), the asthmatic sibs tend to share these alleles when received from their mothers (LOD = 2.82, p = 0.00016). Each of the two chromosomal regions show LOD values (either for tests of linkage, or parent-specific LODs, or both) that are, in order of magnitude, consistent with what has been defined as <<suggestive>> for linkage by Lander and Kruglyak [36], which are expected to occur once per whole genome scan on average. Because of their great hypothesis generating potential, the 6q26 and 10q26 regions as well as asthma and atopy phenotypes were selected for the following G2D and association studies.
###end p 33
###begin title 34
Genome scan results summary.
###end title 34
###begin p 35
Results from the tests of linkage with atopy (top three panels) and asthma (bottom three panels) reported on the LOD scale. For each phenotype, the top panel shows the results of the test of linkage (excess allele sharing), the middle panel shows results from the tests of linkage through mothers (excess allele sharing transmitted from mothers) and the bottom panel shows results from the tests of linkage through fathers (excess allele sharing transmitted from fathers).
###end p 35
###begin title 36
G2D
###end title 36
###begin p 37
###xml 132 136 132 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002907-Wheeler1">[37]</xref>
###xml 931 939 931 939 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002907.s006">Table S5</xref>
###xml 1323 1333 1323 1333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002907.s006">Table S5-A</xref>
###xml 1586 1596 1586 1596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002907.s006">Table S5-B</xref>
###xml 1723 1727 1723 1727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002907-WillsKarp1">[38]</xref>
###xml 1774 1778 1774 1778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002907-Becker1">[39]</xref>
###xml 1794 1802 1794 1802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002907.s007">Table S6</xref>
###xml 1871 1875 1871 1875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002907-Wheeler1">[37]</xref>
###xml 2438 2446 2438 2446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002907.s008">Table S7</xref>
###xml 2674 2682 2674 2682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002907.s008">Table S7</xref>
We applied the two algorithms PHENOTYPE and KNOWN GENES to the 6q26 and 10q26.3 regions. For the PHENOTYPE method, we used the OMIM [37] record 600807 as input, particularly the MeSH C terms from the MEDLINE references in OMIM entry 600807 which deals with susceptibility to asthma and asthma related traits. The most prevailing MeSH C terms are "Asthma" and "Bronchial Hyperreactivity", but the list also includes "Hypersensitivity", "Respiratory Hypersensitivity" and "Eosinophilia". We thus considered that the terms that refer to asthma were "Asthma" and "Bronchial Hyperreactivity" and that the terms that refer to atopy were "Hypersensitivity", "Respiratory Hypersensitivity" and "Eosinophilia". The highest scoring GO terms, associated to these MeSH C terms, describe a variety of molecular functions and processes that include leukotriene and interleukin signaling, glutathione metabolism, etc (see header of supplementary Table S5). We applied this method to the 6q26 region between D6S476 and D6S305, the two markers directly flanking the linkage peak seen in the region, which corresponds to the 10.48 MB band between positions 151,685,574 and 162,165,587 of chromosome 6. After discarding candidates that did not overlap with any known or hypothetical Entrez Gene sequence, 16 genes remained (see supplementary Table S5-A). A similar analysis was carried between D10S1223 and D10S1248, the two markers directly flanking the linkage peak in 10q26.3, between positions 129,150,822 and 130,982,363 in chromosome 10. In that case, 12 candidates were obtained (see supplementary Table S5-B). For the KNOWN GENES method, we compiled a list of genes reported to be associated with asthma and atopy from the literature [38] and from the Genetic Association Database GAD [39] (supplementary Table S6). We then extracted the GO annotation of those genes in Entrez Gene [37]. We derived a scoring system for the candidates according to the minimal semantic distance between their GO annotation and the ones from the compiled known-gene list. For example, genes annotated with GO terms such as "dipeptidyl-peptidase IV activity" or "chemokine receptor binding" would score high as candidates. The method takes into account the hierarchical structure of GO as well as the specificity of GO terms. In that sense, similarity with more infrequent terms receive higher scores. For the complete list of GO terms see the header of supplementary Table S7. We applied the KNOWN GENES method to both regions 6q26 and 10q26.3, obtaining 15 and 10 genes, respectively, after filtering out those candidates that did not overlap with either known or hypothetical genes (see supplementary Table S7).
###end p 37
###begin title 38
Use of a complementary method based on genomic sequence
###end title 38
###begin p 39
###xml 68 72 68 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002907-LopezBigas1">[40]</xref>
###xml 505 510 505 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TFB1M</italic>
###xml 525 530 525 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RGS17</italic>
###xml 548 551 548 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VIP</italic>
We applied the G2D complementary Disease Gene Prediction (DGP) tool [40] to both genetically linked regions in order to predict the involvement of genes in inherited disease by their sequence features. This method analyses the probability of a gene to be associated with any disease phenotype. Genes with no associated phenotype and a probability greater than 0.7 were retained. With this criterion the DGP method identified one candidate in chromosome 10 (MMP21) and three candidates in the 6q26 region: TFB1M [MIM:607033], RGS17 [MIM:607191] and VIP [MIM:192320].
###end p 39
###begin title 40
Final list of candidate genes
###end title 40
###begin p 41
###xml 210 217 210 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002907-t002">Table 2</xref>
###xml 417 420 417 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LPA</italic>
###xml 422 426 422 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOX3</italic>
###xml 428 432 428 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNX9</italic>
###xml 434 438 434 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VIL2</italic>
###xml 440 443 440 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VIP</italic>
###xml 445 450 445 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADAM8</italic>
###xml 452 457 452 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DOCK1</italic>
###xml 459 464 459 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FANK1</italic>
###xml 466 472 466 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GPR123</italic>
###xml 477 482 477 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPRE</italic>
###xml 502 509 502 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002907-t002">Table 2</xref>
Genes that received the higher scores in the pre-selected lists, and those that were pointed by the two different analyses were preferred, allowing the construction of a list of 17 candidates (displayed in the Table 2). We then applied a candidate gene approach to select a final list of ten genes with the best biological potential related to asthma pathophysiology for genotyping (five in each chromosomal region): LPA, NOX3, SNX9, VIL2, VIP, ADAM8, DOCK1, FANK1, GPR123 and PTPRE (marked in bold in Table 2).
###end p 41
###begin title 42
Genes identified by G2D data mining analysis and those selected for the association study based on their number of appearance in G2D analyses and on their biological function.
###end title 42
###begin p 43
Genes marked in bold indicate that they have been selected for the association study. NA = Not available.
###end p 43
###begin p 44
Gene symbol, chromosomal location and GeneID number (Entrez Gene identifier in the NCBI database ()).
###end p 44
###begin p 45
Appears in at least two G2D analyses.
###end p 45
###begin p 46
From NCBI () and GeneCards () databases.
###end p 46
###begin title 47
Association Study
###end title 47
###begin p 48
###xml 115 123 115 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002907.s003">Table S2</xref>
###xml 327 335 327 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002907.s003">Table S2</xref>
###xml 768 772 768 772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002907-Li1">[31]</xref>
###xml 973 980 973 980 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002907.s001">Text S1</xref>
A final panel of 91 SNPs (75 tagSNPs and 16 non-tagSNPs) was selected among the ten candidate genes (supplementary Table S2). Of these, four were non-polymorphic, six failed Sequenom genotyping assays, none presented deviation from Hardy-Weinberg equilibrium (p-values >0.001) and one presented more than two Mendelian errors (Table S2). For the remaining 80 SNPs, genotypes of individuals with Mendelian errors were considered as missing data in the FBAT analyses. Genotyping presented a mean success rate of 99.0% for the Sequenom assays and a mean success rate of 98.3% for the TaqMan assays. Accounting for the residual correlation between the tagSNPs, it is estimated that the 80 partially correlated SNPs correspond to an effective number of 59 independent ones [31]. As for the effective number of phenotypes, simulation indicates that the three studied phenotypes (asthma, atopy and allergic asthma) correspond to 1.75 effective independent ones (see supplementary Text S1 file). Accordingly, the estimated total effective number of independent tests is 103.25 (59 effective independent SNPsx1.75 effective independent phenotypes). Thus, applying Sidak correction, the p-value threshold of significance is estimated to be 0.000483.
###end p 48
###begin p 49
###xml 276 283 276 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002907-t003">Table 3</xref>
The FBAT single marker analyses were performed under an additive genetic model for each SNP and the three studied phenotypes. For the sake of brevity, only results showing a p-value under 0.05 before correction for multiple testing for one or more phenotypes are presented in Table 3. For the asthma phenotype, minor alleles LPA_rs12175867C, GPR123_rs11101913T, GPR123_rs11101932T and GPR123_rs12257731A were overtransmitted to the asthmatic probands, suggesting a susceptibility effect of these alleles for asthma (0.0085<p<0.047). Inversely, minor alleles DOCK1_rs1051039G, PTPRE_rs4369314A and PTPRE_rs7081735G were undertransmitted to the asthmatic probands, suggesting a protective effect of these alleles for asthma (0.010<p<0.049). For the atopy phenotype, only ADAM8_rs11101672G and PTPRE_rs7081735G minor alleles have been undertransmitted to the atopic probands, suggesting a protective effect (p = 0.039 and 0.037, respectively). Finally, for the allergic asthma phenotype, minor alleles LPA_rs12175867C, GPR123_rs11101913T, GPR123_rs11101932T and GPR123_rs12257731A were overtransmitted to the allergic asthmatic probands, suggesting a susceptibility effect of these alleles for allergic asthma (0.035<p<0.041). Inversely, minor alleles ADAM8_rs11101672G, GPR123_rs11101916A, GPR123_rs761777G, PTPRE_rs11016002A, PTPRE_rs4002572C and PTPRE_rs7081735G were undertransmitted to the allergic asthmatic probands, suggesting a protective effect of these alleles for allergic asthma (0.000463<p<0.037). None of the SNPs reported above showed a significantly greater extent of transmission distortion from mothers than from fathers, thus not providing insights to the observed parental distortions seen in the linkage results (not shown).
###end p 49
###begin title 50
Significant Family-Based Association Test (FBAT) results between the ten G2D candidate genes studied SNPs and asthma, atopy and allergic asthma phenotypes under an additive genetic model.
###end title 50
###begin p 51
Abbreviations used: SNP = Single nucleotide polymorphism, MAF = Minor allele frequency, N = Number of families contributing to the statistic, Z = Z score, P = p-value (significance threshold of 0.000483; p-values under are marked in bold).
###end p 51
###begin title 52
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPRE</italic>
PTPRE Sequencing
###end title 52
###begin p 53
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPRE</italic>
###xml 313 321 313 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002907-g002">Figure 2</xref>
###xml 332 337 332 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPRE</italic>
###xml 511 518 511 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002907-t004">Table 4</xref>
###xml 602 607 602 607 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPRE</italic>
PTPRE rs7081735 shows the strongest association to allergic asthma (p = 0.000463) and is the only SNP shown to be significant after multiple testing correction (corrected p = 0.0478). We thus sequenced strategic genomic regions around the rs7081735, including coding regions in order to identify causal mutation. Figure 2 shows the PTPRE sequenced regions, the rs7081735 localization and the nine identified variants (diamonds), including four novel ones (c.86172A>G, c.140901G>A, c.140903G>A and c.141102C>T) (Table 4). It is worth to note that any of these identified polymorphisms may affect either PTPRE isoforms. A family-based association analysis has been performed between the three studied phenotypes and variants presenting a MAF over 0.05 that were not included in the first genotyping panel, which was the case for four of the nine identified variants (rs7911506, c.86172A>G, rs7895103 and c.140901G>A). Only rs7895103 showed a modest association with asthma, at a level that does not provide additional insights (p = 0.013, compared to p = 0.000463 for rs7081735).
###end p 53
###begin title 54
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPRE</italic>
PTPRE gene sequenced regions and identified SNPs scaled location.
###end title 54
###begin p 55
###xml 118 125 118 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002907-t004">Table 4</xref>
###xml 343 348 337 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPRE</italic>
The black thick boxes above the gene define its sequenced parts, which are identified by the same numbers used in the Table 4, in which exact chromosomal positions are available. Studied SNPs are represented below the gene. The TagSNPs correspond to an asterisk (*) and the SNPs identified by sequencing correspond to a diamond (lozenge). All PTPRE numbers for the discovered SNPs are based on the mRNA sequence NM_006504 (variant 1, receptor form) and from the NCBI () SNP database (build 127). Image source: HapMap () October 2007 (Genome Browser, , version 1.69); modified according to our study design.
###end p 55
###begin title 56
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPRE</italic>
PTPRE sequenced regions and characteristics of identified SNPs.
###end title 56
###begin p 57
SNPs marked in bold have been genotyped and analyzed.
###end p 57
###begin p 58
Abbreviations used: bp = base pairs, SNP = single nucleotide polymorphism, MAF = Minor allele frequency, SLSJ = Saguenay-Lac-St-Jean, CEU = CEPH Utah residents with ancestry from northern and western Europe, NA = Not available.
###end p 58
###begin p 59
Base pair numbering according to NCBI () genome assembly (Build 36.2).
###end p 59
###begin p 60
If known from NCBI SNP and Ensembl () databases, reported by the NCBI rs#.
###end p 60
###begin p 61
Calculated on 39 individuals originating from the SLSJ population.
###end p 61
###begin p 62
Obtained from the HapMap international project database ().
###end p 62
###begin title 63
Replication Study
###end title 63
###begin p 64
###xml 21 26 21 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPRE</italic>
###xml 203 207 203 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002907-The1">[34]</xref>
###xml 904 909 904 909 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPRE</italic>
###xml 955 962 955 962 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002907-t003">Table 3</xref>
###xml 1227 1232 1227 1232 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPRE</italic>
Considering that the PTPRE rs7081735 association to allergic asthma is the strongest in the SLSJ sample, we evaluated it in an independent familial cohort, the Childhood Asthma Management Program (CAMP) [34]. The genotyping completion rate was 96% and no discordance was observed upon repeat genotyping of two random plates. The minor allele frequency was 0.33 and was in Hardy-Weinberg equilibrium (p = 0.90). Family-based association showed no significant association for asthma or atopy phenotypes (data not shown). However, to ensure that the selection of the CAMP study for the replication is appropriate and to demonstrate that the association found could result from a childhood subset of asthma instead of an adulthood one, we stratified the SLSJ association analyses considering only the probands that reported an asthma age of onset below 12 years old. Thus, the positive association found for PTPRE rs7081735 and allergic asthma (p = 0.000463, Table 3) remains significant when considering only those probands (Family number = 74; Z for the minor allele = -3.166; p = 0.001546). Even with the loss of statistical power due to the stratified analysis, this comparison allowed to assume that the association found for PTPRE is probably more related to a childhood asthma, comforting the choice of the CAMP cohort as a replication study.
###end p 64
###begin title 65
Discussion
###end title 65
###begin p 66
###xml 389 393 389 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002907-PerezIratxeta1">[17]</xref>
###xml 395 399 395 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002907-PerezIratxeta2">[18]</xref>
###xml 490 493 490 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LPA</italic>
###xml 495 500 495 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADAM8</italic>
###xml 502 507 502 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DOCK1</italic>
###xml 509 515 509 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GPR123</italic>
###xml 520 525 520 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPRE</italic>
###xml 645 650 645 650 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPRE</italic>
This study proposes a novel approach for the selection of candidate genes for asthma association studies using the computational G2D tool to find genetic determinants for this disease. Based on a genome-wide scan performed in an asthmatic familial sample from the SLSJ founder population, we selected the two best-linked regions (6q26 and 10q26.3) and applied the G2D data mining approach [17], [18] to identify ten candidate genes for an association in the SLSJ sample. Among these, five (LPA, ADAM8, DOCK1, GPR123 and PTPRE) presented modest associations with asthma, atopy or allergic asthma. After corrections for multiple testing, only the PTPRE rs7081735 association to allergic asthma remained significant. These findings demonstrate that the G2D tool can be useful in the selection of candidate genes for asthma genetic studies.
###end p 66
###begin p 67
###xml 12 17 12 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPRE</italic>
Because the PTPRE association to allergic asthma remained significant after correction for multiple testing, we sequenced strategic regions around the rs7081735, aiming to find the causal mutation. Sequencing allowed the identification of five known and four novel variants. Testing four SNPs with MAF >0.05 did not identify additional associated SNPs with asthma or atopy related phenotypes in the SLSJ sample. Thus, the rs7081735, located in the 5' untranslated region, could be the causal variant, or be in linkage disequilibrium with an unknown causal mutation.
###end p 67
###begin p 68
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPRE</italic>
###xml 292 296 292 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002907-Alonso1">[41]</xref>
###xml 298 302 298 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002907-Li2">[42]</xref>
###xml 304 309 304 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPRE</italic>
###xml 372 376 372 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002907-Nakamura1">[43]</xref>
###xml 411 415 411 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002907-Tanuma1">[44]</xref>
###xml 580 584 580 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002907-Schumann1">[45]</xref>
###xml 869 873 857 861 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002907-Sully1">[46]</xref>
###xml 884 889 872 877 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPRE</italic>
###xml 1035 1040 1023 1028 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPRE</italic>
###xml 1066 1070 1054 1058 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002907-Wabakken1">[47]</xref>
###xml 1138 1143 1126 1131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPRE</italic>
###xml 1387 1392 1375 1380 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPRE</italic>
###xml 601 605 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 942 947 <span type="species:ncbi:9606">human</span>
PTPRE is a member of the protein tyrosine phosphatase (PTPs) family, which includes genes that are important regulators of signal transduction pathways involved in various cellular processes such as control of metabolic pathways, cellular adhesion, cell cycle progression and immune response [41], [42]. PTPRE encodes two different isoforms, cytoplasmic and transmembrane [43], based on its different promoters [44]. PTPs receptors participate in transmembrane signaling and cellular adhesion processes, whereas intracellular PTPs take part in signal transduction within the cell [45]. For example in mice, PTPepsilon-deficient macrophages present abnormalities in the regulation of the respiratory burst and the production of cytokines in response to bacterial lipopolysaccharide, suggesting a role of the PTPepsilon isoform in inflammation as well as in host defense [46]. However, PTPRE has been shown to be highly expressed in peripheral human monocytes and granulocytes, and antigen-receptor stimulation induces the expression of PTPRE in activated lymphocytes [47]. These observations and our finding suggest a protective effect of PTPRE in allergic asthma, and lead us to hypothesize that this potential protective role could involve the leukocyte cellular processes in the limitation of lung inflammation following an allergen sensitization. Further work is needed to define the PTPRE possible role in asthma pathophysiology.
###end p 68
###begin p 69
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPRE</italic>
###xml 256 260 256 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002907-Lemire2">[48]</xref>
###xml 262 266 262 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002907-Hersh1">[49]</xref>
###xml 312 317 312 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPRE</italic>
###xml 441 445 441 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002907-Reed1">[50]</xref>
###xml 447 451 447 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002907-Koh1">[51]</xref>
###xml 623 627 623 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002907-Hirschhorn1">[52]</xref>
###xml 698 702 698 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002907-Heyer1">[11]</xref>
###xml 703 707 703 707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002907-Lander1">[16]</xref>
###xml 854 858 854 858 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002907-Hirschhorn1">[52]</xref>
###xml 910 915 910 915 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPRE</italic>
The PTPRE rs7081735 association has been evaluated in the independent CAMP cohort. Results showed no positive association for asthma and atopic phenotypes. Taking into account that the SLSJ and the CAMP studies are both family-based designed, well powered [48], [49] and presenting a childhood onset asthma, the PTPRE association lack of replication in the CAMP study can be explained by other reasons: natural variability of asthma history [50], [51], differences of proband mean age between samples (SLSJ mean age of 18, and CAMP mean age of 8, respectively), differences in the genetic background of the two populations [52] (SLSJ individuals descend predominantly from French European founders [11]-[16] whereas CAMP individuals come from a white North-American admixed population), or population specific gene-gene and gene-environment interactions [52]. Based on these observations, we conclude that the PTPRE rs7081735 association to allergic asthma is more penetrant in the SLSJ population, possibly resulting from an interaction with others genes and/or environmental factors that are more common in this founder population.
###end p 69
###begin p 70
###xml 200 205 200 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPRE</italic>
In summary, this study demonstrates that the G2D tool can be useful in the prioritization of candidate genes for a complex disease as it allowed us to find a novel asthma genetic association with the PTPRE gene in the SLSJ familial asthma sample. This association represents a potential protective factor for asthma pathogenesis, as it is more likely related to a childhood onset asthma. The present genetic study is an example of how the combination of different methodological approaches can be relevant to target asthma genetic determinants and to motivate further genetic and functional investigations.
###end p 70
###begin title 71
Supporting Information
###end title 71
###begin p 72
(0.03 MB DOC)
###end p 72
###begin p 73
Click here for additional data file.
###end p 73
###begin p 74
Genome-wide scan Saguenay-Lac-St-Jean subjects clinical characteristics and studied phenotypes
###end p 74
###begin p 75
(0.06 MB DOC)
###end p 75
###begin p 76
Click here for additional data file.
###end p 76
###begin p 77
Characteristics of the 91 selected SNPs
###end p 77
###begin p 78
(0.25 MB DOC)
###end p 78
###begin p 79
Click here for additional data file.
###end p 79
###begin p 80
Taqman PCR conditions
###end p 80
###begin p 81
(0.06 MB DOC)
###end p 81
###begin p 82
Click here for additional data file.
###end p 82
###begin p 83
Oligonucleotides used for PTPRE sequencing
###end p 83
###begin p 84
(0.05 MB DOC)
###end p 84
###begin p 85
Click here for additional data file.
###end p 85
###begin p 86
Genes selected by G2D << PHENOTYPE >> analysis
###end p 86
###begin p 87
(0.07 MB DOC)
###end p 87
###begin p 88
Click here for additional data file.
###end p 88
###begin p 89
Genes known or suspected to be associated with asthma that were considered for the G2D <<KNOWN GENES>> analysis
###end p 89
###begin p 90
(0.07 MB DOC)
###end p 90
###begin p 91
Click here for additional data file.
###end p 91
###begin p 92
Genes selected by G2D << KNOWN GENES >> analysis
###end p 92
###begin p 93
(0.06 MB DOC)
###end p 93
###begin p 94
Click here for additional data file.
###end p 94
###begin p 95
###xml 1167 1172 <span type="species:ncbi:9606">Women</span>
###xml 1220 1225 <span type="species:ncbi:9606">human</span>
We thank families of the Saguenay-Lac-St-Jean for their participation in this study. We also thank Janet Murphy for her participation in the genome scan as well as Alexandre Belisle, Pierre Lepage and Charleen Salesse for the genotyping assays. K. Tremblay is an AllerGen PhD trainee and is supported by the Fondation de l'Universite Laval studentship. T.J. Hudson received an Investigator Award from the Canadian Institutes of Health Research (CIHR) and a Clinician-scientist Award in Translational Research from the Burroughs Wellcome Fund. M.A. Andrade-Navarro holds a Canada Research Chair in Bioinformatics. C. Laprise is the chairholder of the Canada Research Chair () on genetic determinants in asthma and the director of the Genetics platform of the Respiratory Health Network of the Fonds de la recherche en sante du Quebec. We also thank all subjects of the CAMP study for their ongoing participation. We acknowledge the CAMP investigators and research team, supported by NHLBI, for collection of CAMP Genetic Ancillary Study data. All work on data collected from the CAMP Genetic Ancillary Study was conducted at the Channing Laboratory of the Brigham and Women's Hospital under appropriate CAMP policies and human subject's protections.
###end p 95
###begin title 96
References
###end title 96
###begin article-title 97
The pathophysiology of asthma.
###end article-title 97
###begin article-title 98
Genetics of asthma and allergic disease.
###end article-title 98
###begin article-title 99
The role of genetics in the development of asthma and atopy.
###end article-title 99
###begin article-title 100
The genetics of asthma.
###end article-title 100
###begin article-title 101
Present status on the genetic studies of asthma.
###end article-title 101
###begin article-title 102
Finding genes influencing susceptibility to complex diseases in the post-genome era.
###end article-title 102
###begin article-title 103
A second-generation genomewide screen for asthma-susceptibility alleles in a founder population.
###end article-title 103
###begin article-title 104
A susceptibility locus for asthma-related traits on chromosome 7 revealed by genome-wide scan in a founder population.
###end article-title 104
###begin article-title 105
Association studies for asthma and atopic diseases: a comprehensive review of the literature.
###end article-title 105
###begin article-title 106
Asthma genetics 2006: the long and winding road to gene discovery.
###end article-title 106
###begin article-title 107
Variability of the genetic contribution of Quebec population founders associated to some deleterious genes.
###end article-title 107
###begin article-title 108
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human genetics: lessons from Quebec populations.
###end article-title 108
###begin article-title 109
Linkage disequilibrium analysis in young populations: pseudo-vitamin D-deficiency rickets and the founder effect in French Canadians.
###end article-title 109
###begin article-title 110
ARSACS, a spastic ataxia common in northeastern Quebec, is caused by mutations in a new gene encoding an 11.5-kb ORF.
###end article-title 110
###begin article-title 111
Location score and haplotype analyses of the locus for autosomal recessive spastic ataxia of Charlevoix-Saguenay, in chromosome region 13q11.
###end article-title 111
###begin article-title 112
Genetic dissection of complex traits.
###end article-title 112
###begin article-title 113
G2D: a tool for mining genes associated with disease.
###end article-title 113
###begin article-title 114
Update of the G2D tool for prioritization of gene candidates to inherited diseases.
###end article-title 114
###begin article-title 115
Association of vitamin D receptor genetic variants with susceptibility to asthma and atopy.
###end article-title 115
###begin article-title 116
Association study between the CX3CR1 gene and asthma.
###end article-title 116
###begin article-title 117
Association of urokinase-type plasminogen activator with asthma and atopy.
###end article-title 117
###begin article-title 118
Allele-sharing models: LOD scores and accurate linkage tests.
###end article-title 118
###begin article-title 119
Parametric and nonparametric linkage analysis: a unified multipoint approach.
###end article-title 119
###begin article-title 120
A simple nonparametric multipoint procedure to test for linkage through mothers or fathers as well as imprinting effects in the presence of linkage.
###end article-title 120
###begin article-title 121
Gene ontology: tool for the unification of biology. The Gene Ontology Consortium.
###end article-title 121
###begin article-title 122
Haploview: analysis and visualization of LD and haplotype maps.
###end article-title 122
###begin article-title 123
iPLEX assay: Increased plexing efficiency and flexibility for MassArray system through single base primer extension with mass-modified terminators.
###end article-title 123
###begin article-title 124
Family-based tests of association in the presence of linkage.
###end article-title 124
###begin article-title 125
Family-based tests for associating haplotypes with general phenotype data: application to asthma genetics.
###end article-title 125
###begin article-title 126
Implementing a unified approach to family-based tests of association.
###end article-title 126
###begin article-title 127
Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix.
###end article-title 127
###begin article-title 128
A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other.
###end article-title 128
###begin article-title 129
[Population files and database management: the BALSAC database and the INGRES/INGRID system].
###end article-title 129
###begin article-title 130
The Childhood Asthma Management Program (CAMP): design, rationale, and methods.
###end article-title 130
###begin article-title 131
###xml 49 57 <span type="species:ncbi:9606">children</span>
Long-term effects of budesonide or nedocromil in children with asthma.
###end article-title 131
###begin article-title 132
Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results.
###end article-title 132
###begin article-title 133
Database resources of the National Center for Biotechnology Information.
###end article-title 133
###begin article-title 134
Time to draw breath: asthma-susceptibility genes are identified.
###end article-title 134
###begin article-title 135
The genetic association database.
###end article-title 135
###begin article-title 136
###xml 61 66 <span type="species:ncbi:9606">human</span>
Genome-wide identification of genes likely to be involved in human genetic disease.
###end article-title 136
###begin article-title 137
###xml 37 42 <span type="species:ncbi:9606">human</span>
Protein tyrosine phosphatases in the human genome.
###end article-title 137
###begin article-title 138
###xml 89 94 <span type="species:ncbi:9606">human</span>
Form, function, and regulation of protein tyrosine phosphatases and their involvement in human diseases.
###end article-title 138
###begin article-title 139
Molecular cloning of a novel cytoplasmic protein tyrosine phosphatase PTP epsilon.
###end article-title 139
###begin article-title 140
Distinct promoters control transmembrane and cytosolic protein tyrosine phosphatase epsilon expression during macrophage differentiation.
###end article-title 140
###begin article-title 141
###xml 67 72 <span type="species:ncbi:9606">human</span>
Cytokine-induced transcription of protein-tyrosine-phosphatases in human astrocytoma cells.
###end article-title 141
###begin article-title 142
Functional abnormalities in protein tyrosine phosphatase epsilon-deficient macrophages.
###end article-title 142
###begin article-title 143
###xml 14 19 <span type="species:ncbi:9606">human</span>
Expression of human protein tyrosine phosphatase epsilon in leucocytes: a potential ERK pathway-regulating phosphatase.
###end article-title 143
###begin article-title 144
Transmission-ratio distortion and allele sharing in affected sib pairs: a new linkage statistic with reduced bias, with application to chromosome 6q25.3.
###end article-title 144
###begin article-title 145
Comprehensive Testing of Positionally Cloned Asthma Genes in Two Populations.
###end article-title 145
###begin article-title 146
The natural history of asthma.
###end article-title 146
###begin article-title 147
The natural history of asthma from childhood to adulthood.
###end article-title 147
###begin article-title 148
A comprehensive review of genetic association studies.
###end article-title 148
###begin p 149
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 149
###begin p 150
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: The Canadian Institutes of Health Research and the Respiratory Health Network of the Fonds de la recherche en sante du Quebec financially supported this work. The Childhood Asthma Management Program Genetics Ancillary Study is supported by U01 HL075419, U01 HL65899, P01 HL083069, R01 HL 086601, and T32 HL07427 from the National Heart, Lung and Blood Institute, National Institutes of Health.
###end p 150

